Our Products
Comprehensive Pharmaceutical
Product Portfolio
EMEDICS PHARMACEUTICALS LIMITED is implementing a phased manufacturing approach to build sustainable production capacity. Our product portfolio is designed to address Africa's major disease burden, focusing on priority therapeutic areas that support national and regional health priorities.
Each phase of our manufacturing strategy expands our capabilities and product range, ensuring we can meet the growing demand for quality-assured medicines across the continent.
3
Manufacturing PhasesThree Phases of
Product Manufacturing
EMEDICS is implementing a phased manufacturing approach to build sustainable production
capacity while maintaining the highest quality standards.
Phase I
Liquid & Topical Preparations
Liquid preparations including disinfectants, antiseptics, creams, and ointments. These essential products address basic healthcare needs and infection control.
Phase II
Oral Liquid Medicines
Oral liquid medicines, syrups, and suspensions designed for hospital use and national health programmes, particularly for paediatric and geriatric patients.
Phase III
Tablets & Capsules
Solid oral dosage forms including tablets and capsules, expanding production capacity to serve both domestic Tanzanian and regional East African markets.
Addressing Africa's Major
Disease Burden
EMEDICS manufactures medicines that respond to Africa's major disease burden, focusing on
priority therapeutic areas to support national and regional health priorities.
Infectious Diseases
Antimicrobials, antimalarials, and treatments for communicable diseases prevalent in the region.
Non-Communicable Diseases
Cardiovascular, diabetes, and respiratory medications for the growing NCD burden.
Primary & Maternal Care
Essential medicines for primary healthcare and maternal and child health programmes.
Interested in Our Product Portfolio? Contact Us for More Information
